Marks Group Wealth Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2M | Sell |
28,554
-12,673
| -31% | -$886K | 0.19% | 123 |
|
|
2025
Q1 | $3.03M | Sell |
41,227
-3,725
| -8% | -$274K | 0.29% | 97 |
|
|
2024
Q4 | $2.95M | Buy |
44,952
+1,280
| +3% | +$83.9K | 0.29% | 99 |
|
|
2024
Q3 | $3.4M | Sell |
43,672
-686
| -2% | -$53.4K | 0.32% | 94 |
|
|
2024
Q2 | $3.46M | Buy |
44,358
+1,914
| +5% | +$149K | 0.36% | 88 |
|
|
2024
Q1 | $2.88M | Sell |
42,444
-2,837
| -6% | -$192K | 0.3% | 95 |
|
|
2023
Q4 | $3.05M | Buy |
45,281
+36,789
| +433% | +$2.48M | 0.35% | 91 |
|
|
2023
Q3 | $575K | Buy |
+8,492
| New | +$575K | 0.07% | 197 |
|